Table 1 Numbers and survival proportion of ovarian cancer by age at diagnosis, time period and histology
From: Evaluation of prevalent and incident ovarian cancer co-morbidity
N | (%) | One-year survival (%) | Five-year survival (%) | |||
|---|---|---|---|---|---|---|
All | 11 139 | 9193 | (82.5) | 5201 | (46.7) | |
Age at cancer diagnosis (years) | ||||||
<49 | 1867 | (16.8) | 1739 | (93.1) | 1270 | (68.0) |
50–69 | 5443 | (48.9) | 4782 | (87.9) | 2731 | (50.2) |
>70 | 3829 | (34.4) | 2672 | (69.8) | 1200 | (31.3) |
Year of ovarian cancer diagnosis a | ||||||
1993–1996 | 3438 | (30.9) | 2728 | (79.3) | 1437 | (41.8) |
1997–2001 | 3715 | (33.4) | 3120 | (84.0) | 2024 | (43.7) |
Histologic type | ||||||
Epithelial, high riskb | 8567 | (76.9) | 7078 | (82.6) | 3638 | (42.5) |
Epithelial, medium riskc | 1504 | (13.5) | 1220 | (81.1) | 876 | (58.2) |
Germ cell tumour | 146 | (1.3) | 140 | (95.9) | 130 | (89.0) |
Stroma cell tumour | 452 | (4.1) | 437 | (96.7) | 390 | (86.3) |
Sarcomas | 202 | (1.8) | 115 | (56.9) | 43 | (21.3) |
Other | 268 | (2.4) | 203 | (75.7) | 124 | (46.3) |